Microglia in the Brain Tumor Microenvironment

Allison P Cole1, Eric Hoffmeyer1, Senthilnath Lakshmana Chetty1

  • 1Department of Pediatrics, Division of Hematology/Oncology/Bone Marrow Transplant, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Insights

Microglia, the brain's immune cells, originate from yolk sac macrophages. These cells are vital for brain development, homeostasis, and repair, but also drive glioma growth and present therapeutic targets.

Area of Science:

  • Neuroimmunology
  • Developmental Neuroscience
  • Cancer Biology

Background:

  • Microglia are the primary immune cells of the central nervous system, originating from yolk sac macrophages.
  • Recent technological advancements, including imaging and single-cell RNA-seq, have illuminated microglia's complex biology.
  • These cells are integral to brain development, homeostasis, and injury repair.

Purpose of the Study:

  • To review the ontogeny and fundamental functions of microglia.
  • To elucidate the multifaceted role of microglia within the glioma tumor microenvironment.
  • To highlight the therapeutic potential of targeting microglia in glioma treatment.

Main Methods:

  • Literature review of current knowledge on microglia biology and function.
  • Analysis of the role of microglia in central nervous system development and injury.
  • Examination of microglia's involvement in glioma initiation, progression, and therapeutic response.

Main Results:

  • Microglia originate from primitive yolk sac macrophages and are essential for normal brain function.
  • In gliomas, microglia contribute to tumor growth and metastasis.
  • Microglia also possess effector functions that can be harnessed for anti-glioma therapies.

Conclusions:

  • Understanding microglia generation and function is key to comprehending brain health and disease.
  • Microglia represent a critical component of the glioma microenvironment with dual roles in tumor progression and therapeutic response.
  • Targeting microglia offers promising avenues for novel glioma treatment strategies.